Prof. Tal Dvir, Head of the Sagol Center for Regenerative Biotechnology, Head of the Nanotechnology Center at Tel Aviv University, and Chief Scientist of the biotech company Matricelf. The surgery is ...
- Initial NHHO study targets patients with traumatic SCI who have high rates of HO, which causes abnormal bone growth in soft tissues - BRISBANE, Calif.--(BUSINESS WIRE)--āshibio, a privately held, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback